Slow Capital, Inc. Vertex Pharmaceuticals Inc Transaction History

Slow Capital, Inc.

$617 Million
Q2 2024

A detailed history of Slow Capital, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Slow Capital, Inc. holds 12,665 shares of VRTX stock, worth $6.01 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares

12,665

Previous 12,910 1.9%

Holding current value

$6.01 Million

Previous $5.4 Million 10.01%

% of portfolio

0.96%

Previous 0.86%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	SELL	$392.81 - $485.53 $96,238 - $118,954	-245 Reduced 1.9%	12,665 $5.94 Million
Q1 2024 Apr 17, 2024	SELL	$407.69 - $446.08 $35,469 - $38,808	-87 Reduced 0.67%	12,910 $5.4 Million
Q4 2023 Jan 30, 2024	BUY	$343.0 - $410.68 $17,493 - $20,944	51 Added 0.39%	12,997 $5.29 Million
Q3 2023 Oct 19, 2023	BUY	$338.18 - $362.46 $233,344 - $250,097	690 Added 5.63%	12,946 $4.5 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $230,469 - $257,950	-733 Reduced 5.64%	12,256 $4.31 Million
Q1 2023 Apr 26, 2023	BUY	$283.23 - $323.1 $795,593 - $907,587	2,809 Added 27.59%	12,989 $4.09 Million
Q4 2022 Feb 13, 2023	SELL	$285.76 - $321.48 $75,440 - $84,870	-264 Reduced 2.53%	10,180 $2.94 Million
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $77,493 - $86,464	283 Added 2.79%	10,444 $3.02 Million
Q2 2022 Jul 28, 2022	SELL	$234.96 - $292.55 $112,780 - $140,424	-480 Reduced 4.51%	10,161 $2.86 Million
Q1 2022 May 02, 2022	SELL	$221.42 - $260.97 $140,823 - $165,976	-636 Reduced 5.64%	10,641 $2.78 Million
Q4 2021 Feb 08, 2022	SELL	$177.01 - $223.45 $727,688 - $918,602	-4,111 Reduced 26.72%	11,277 $2.48 Million
Q3 2021 Oct 21, 2021	SELL	$181.39 - $202.99 $7,981 - $8,931	-44 Reduced 0.29%	15,388 $2.79 Million
Q2 2021 Jul 29, 2021	BUY	$187.49 - $221.1 $568,657 - $670,596	3,033 Added 24.46%	15,432 $3.11 Million
Q1 2021 May 20, 2021	BUY	$207.02 - $241.31 $97,506 - $113,657	471 Added 3.95%	12,399 $2.73 Million
Q1 2021 May 05, 2021	BUY	$207.02 - $241.31 $283,617 - $330,594	1,370 Added 12.98%	11,928 $2.56 Million
Q4 2020 Feb 11, 2021	BUY	$207.01 - $276.09 $498,480 - $664,824	2,408 Added 29.55%	10,558 $2.5 Million
Q3 2020 Nov 04, 2020	BUY	$255.65 - $303.1 $144,186 - $170,948	564 Added 7.43%	8,150 $2.22 Million
Q2 2020 Aug 10, 2020	BUY	$225.48 - $295.8 $30,439 - $39,933	135 Added 1.81%	7,586 $2.2 Million
Q1 2020 May 12, 2020	BUY	$199.77 - $247.81 $138,840 - $172,227	695 Added 10.29%	7,451 $1.77 Million
Q4 2019 Feb 14, 2020	SELL	$166.71 - $223.91 $41,010 - $55,081	-246 Reduced 3.51%	6,756 $1.48 Million
Q3 2019 Nov 07, 2019	BUY	$166.23 - $187.09 $478,908 - $539,006	2,881 Added 69.91%	7,002 $1.19 Million
Q2 2019 Aug 01, 2019	BUY	$164.61 - $190.37 $678,357 - $784,514	4,121 New	4,121 $756,000

Others Institutions Holding VRTX

# of Institutions

1,707

Shares Held

226M

Call Options Held

1.2M

Put Options Held

1.59M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Slow Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Slow Capital, Inc. with notifications on news.

Account